SUBSCRIBE
SUBSCRIBE
News   Deals

CryoLife, Inc. Says Medafor, Inc. Rejects its $2/Share Offer

February 18, 2010 | 
1 min read
Bookmark and Share

Reuters -- CryoLife Inc, a maker of implantable devices, said it would consider commencing a tender offer or a proxy contest for Medafor Inc after the privately held company rejected its $2 per share offer.
Mergers & acquisitions
MORE ON THIS TOPIC
3d fatty liver disease isolated on pink background. 3d illustration render
MASH
Madrigal Dives Further Into MASH With up to $4.4B siRNA Deal With Chinese Biotech
February 11, 2026
 · 
2 min read
 · 
Tristan Manalac
3d illustration of a robotic hand holding a medical capsule on blue backdrop with space for text and images. Concept of automated medical treatment.
Artificial intelligence
AI Is Changing Pharma’s Bottom Line Now—But Not Through Splashy Drug Discovery
February 11, 2026
 · 
8 min read
 · 
Annalee Armstrong
Creativity and new ideas in business. Art collage.
Mergers & acquisitions
Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune
February 9, 2026
 · 
2 min read
 · 
Dan Samorodnitsky
Insights
Programmable RNA 2.0: Beyond the First mRNA Revolution
February 5, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker